Symposia: T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Lymphoid Leukemias, Research, Clinical trials, Combination therapy, Adult, Antibody Therapy, Drug development, Lymphomas, Epidemiology, Clinical Research, LGL, Health outcomes research, T Cell lymphoma, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Lymphoid Malignancies, Monoclonal Antibody Therapy, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Lymphoid Leukemias, Research, Clinical trials, Combination therapy, Adult, Antibody Therapy, Drug development, Lymphomas, Epidemiology, Clinical Research, LGL, Health outcomes research, T Cell lymphoma, Diseases, Therapy sequence, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Lymphoid Malignancies, Monoclonal Antibody Therapy, Study Population, Human
Monday, December 9, 2024: 4:30 PM-6:00 PM
Pacific Ballroom Salons 15-17
(Marriott Marquis San Diego Marina)
Moderators:
N. Nora Bennani, MD, Mayo Clinic
and
Tarsheen Sethi, MD, MSc, Yale University School of Medicine
Disclosures:
Bennani: Acrotech Biopharma LLC: Membership on an entity's Board of Directors or advisory committees, Other: Advisory board; Pfizer: Membership on an entity's Board of Directors or advisory committees. Sethi: MERCK: Research Funding.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH